Spots Global Cancer Trial Database for curative surgery
Every month we try and update this database with for curative surgery cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma | NCT02548195 | Cholangiocarcin... | oxaliplatin and... capecitabine | 18 Years - 70 Years | Shanghai Zhongshan Hospital | |
| Value of Diffusion Weighted Magnetic Resonance Imaging in Detection of Recurrent Disease in Surgically Treated Cervical and Endometrial Cancer Patients | NCT01710085 | Cervical Cancer Endometrial Can... | Diffusion weigh... | 18 Years - | Uludag University | |
| A Study, Combination, Immunologic Study of LTX-315 as Adjunct to GV1001 in Patients Following Curative Surgery for Carcinoma | NCT01223209 | Carcinoma | LTX-315 | 18 Years - | Lytix Biopharma AS | |
| CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence | NCT06037980 | Biliary Tract C... Cholangiocarcin... | Gemcitabine Nab paclitaxel Cisplatin Curative Surger... Capecitabine | 18 Years - 75 Years | Gruppo Oncologico del Nord-Ovest | |
| Induction Therapy With Intercalated Tyrosine Kinase Inhibitor (TKI) and Chemotherapy in NSCLC With Activating Epidermal Growth Factor Receptor (EGFR) Mutation in Stages II-IIIB | NCT02326285 | Non-squamous No... Non-squamous No... Non-squamous No... Activating EGFR... NSCLC | Gefitinib docetaxel cisplatin Surgery | 18 Years - | AIO-Studien-gGmbH | |
| CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence | NCT06037980 | Biliary Tract C... Cholangiocarcin... | Gemcitabine Nab paclitaxel Cisplatin Curative Surger... Capecitabine | 18 Years - 75 Years | Gruppo Oncologico del Nord-Ovest | |
| Induction Therapy With Intercalated Tyrosine Kinase Inhibitor (TKI) and Chemotherapy in NSCLC With Activating Epidermal Growth Factor Receptor (EGFR) Mutation in Stages II-IIIB | NCT02326285 | Non-squamous No... Non-squamous No... Non-squamous No... Activating EGFR... NSCLC | Gefitinib docetaxel cisplatin Surgery | 18 Years - | AIO-Studien-gGmbH | |
| Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma | NCT02548195 | Cholangiocarcin... | oxaliplatin and... capecitabine | 18 Years - 70 Years | Shanghai Zhongshan Hospital | |
| HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer | NCT03387553 | Breast Cancer Breast Cancer F... Breast Cancer, ... Invasive Breast... HER2-positive B... HER2 Positive B... Stage II Breast... Stage III Breas... | Dendritic Cell ... Neoadjuvant Che... Curative Surger... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
